Nasostop - 0.1% & 0.5% Nasal Drops 15 ml

Symptomatic treatment of nasal congestion in chronic, perennial and acute rhinitis (including allergic and associated with flowering), sinusitis.

Tradename: Nasostop

Nasostop

Composition and form of release: Active ingredient: Xylometazoline hydrochloride 1mg\1ml

Nasal drops in the form of a clear, colorless solution, plastic bottle.

Pharmachologic effect: Vasoconstrictor for topical use in ENT practice. When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease. With rhinitis, it facilitates nasal breathing.

Do not use the drug for more than 7 days to avoid atrophy of the nasal mucosa.

Indications : Symptomatic treatment of nasal congestion in chronic, perennial and acute rhinitis (including allergic and associated with flowering), sinusitis.

* Contraindications : Nasostop 0.1% - Individual intolerance to the components of the drug.

- Patients after removal of the pituitary gland or other surgical interventions on the brain in history.

- Children under 12 years of age.

- Angle-closure glaucoma.

- Atrophic rhinitis.

- Arterial hypertension, tachycardia, severe atherosclerosis.

- Hyperthyroidism.

Use during pregnancy and lactation: During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and fetus by the attending physician.

* Contraindications: Nasostop 0.5% - Individual intolerance to the components of the drug.

- Patients after removal of the pituitary gland or other surgical interventions on the brain in history.

- Children under 6 years of age.

- Angle-closure glaucoma.

- Atrophic rhinitis.

- Arterial hypertension, tachycardia, severe atherosclerosis.

- Hyperthyroidism.

- Diabetes.

- Pheochromocytoma.

- Inflammation of the skin and mucous membranes of the vestibule of the nose.

Side effects: With frequent and / or prolonged use: irritation of the mucous membrane, burning, tingling, sneezing, dryness of the nasal mucosa, hypersecretion.

Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, heart rhythm disturbances, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.

With prolonged use in high doses: depressive state.

Dosing regimen: Nasostop 0.1% Intranasally. 2-3 drops in each nasal passage 2-3 times a day.

Dosing regimen: Nasostop 0.5% Intranasally. In children from 6 to 12 years old, 1-2 drops in each nasal passage 1-2 times a day

Storage method: Store at a temperature not exceeding 30 degrees

Package: Bottle 15 ml